Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
Carpenter TO, Imel EA, Ruppe MD, Weber, TJ, Klausner MK, Wooddell MM, Kawakami T, Ito T, Zhang X, Humphrey J, Insogna K, Peacock, J Clin Invest, 1/1/2014The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institut...
Seymour L, Ivy SP, Sargent D, Spriggs D, Baker L, Rubinstein L, Ratain MJ, Le Blanc M, Stewart D, Crowley J, Groshen S, Humphrey JS, West P, Berry D, Clin Cancer Res, 1/15/2010GCP Data Quality for Early Clinical Development
Rock EP, Molloy VJ, and Humphrey JS, Clin Cancer Res, 1/1/2010
